TNFRSF1A and lymphopenia: The use of TNFR agonists in patients undergoing T cell-depleted induced-lymphopenia with the purpose of tipping the balance of Tregs over conventional T cells during the course of immune reconstitution in transplant patients would be a pertinent approach to limit long-term administration of immunosuppression and modulate the course of graft rejection or GvHD.